Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Macrogenics (MGNX)

Macrogenics (MGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,106
  • Shares Outstanding, K 61,459
  • Annual Sales, $ 77,450 K
  • Annual Income, $ -202,120 K
  • 60-Month Beta 1.91
  • Price/Sales 2.75
  • Price/Cash Flow N/A
  • Price/Book 1.49
Trade MGNX with:

Options Overview Details

View History
  • Implied Volatility 134.85% ( -129.70%)
  • Historical Volatility 70.05%
  • IV Percentile 67%
  • IV Rank 27.33%
  • IV High 422.73% on 07/28/22
  • IV Low 26.57% on 06/06/22
  • Put/Call Vol Ratio 0.06
  • Today's Volume 19
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 3,014
  • Open Int (30-Day) 3,022

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.31
  • Number of Estimates 4
  • High Estimate 0.33
  • Low Estimate -0.74
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +63.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.93 +26.43%
on 09/23/22
4.32 -14.02%
on 09/09/22
-0.53 (-12.50%)
since 09/02/22
3-Month
2.93 +26.43%
on 09/23/22
5.41 -31.42%
on 08/12/22
+0.66 (+21.64%)
since 07/01/22
52-Week
2.13 +74.18%
on 06/16/22
22.68 -83.64%
on 11/05/21
-16.56 (-81.70%)
since 10/04/21

Most Recent Stories

More News
Why MacroGenics Stock Sank Today

An analyst had a fresh new take on the company's prospects, and it wasn't all that positive.

MGNX : 3.71 (+6.00%)
Wall Street Analysts Predict a 291% Upside in MacroGenics (MGNX): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 291% in MacroGenics (MGNX). While the effectiveness of this highly sought-after metric is questionable, the positive...

MGNX : 3.71 (+6.00%)
MacroGenics (MGNX) Q2 2022 Earnings Call Transcript

MGNX earnings call for the period ending June 30, 2022.

MGNX : 3.71 (+6.00%)
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of 30.93% and 78.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MGNX : 3.71 (+6.00%)
IMCC : 0.3875 (-4.51%)
MacroGenics Provides Update on Corporate Progress and Second Quarter 2022 Financial Results

First patient dosed in Phase 1 study of MGD024 in CD123-positive hematologic malignanciesPlan to initiate MGC018 Phase 2/3 study in prostate cancer by...

MGNX : 3.71 (+6.00%)
National Vision (EYE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

National Vision (EYE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EYE : 35.18 (+5.68%)
MGNX : 3.71 (+6.00%)
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for

MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MGNX : 3.71 (+6.00%)
NUVA : 44.40 (+1.00%)
LeMaitre Vascular (LMAT) Lags Q2 Earnings Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -9.38% and 2.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LMAT : 52.25 (+2.29%)
MGNX : 3.71 (+6.00%)
MacroGenics Announces Date of Second Quarter 2022 Financial Results Conference Call

ROCKVILLE, MD, July 25, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing...

MGNX : 3.71 (+6.00%)
JMP Securities Sticks to Its Buy Rating for MacroGenics (MGNX)

In a report released today, Silvan Tuerkcan from JMP Securities maintained a Buy rating on MacroGenics (MGNX – Research Report), with a price target of $20.00. The company's shares closed last Monday...

MGNX : 3.71 (+6.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

3rd Resistance Point 3.94
2nd Resistance Point 3.84
1st Resistance Point 3.77
Last Price 3.71
1st Support Level 3.60
2nd Support Level 3.50
3rd Support Level 3.43

See More

52-Week High 22.68
Fibonacci 61.8% 14.83
Fibonacci 50% 12.41
Fibonacci 38.2% 9.98
Last Price 3.71
52-Week Low 2.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar